WEST PHARMACEUTICAL SERVICES, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $33.20 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-07-23
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $33.20M.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $34.00M.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $34.70M.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $35.20M.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $33.20M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $34.00M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $34.70M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $35.20M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $35.00M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $32.00M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $29.70M 10-K · filed 2026-02-17 |
| 2024-09-30 | $31.90M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $31.00M 10-Q · filed 2024-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |